Binder Br
Impact in
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
- Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms
Papers in
-
- Protease and Inhibitor Mechanisms 8
-
- Glycosylation and Glycoproteins Research 1
- Angiogenesis and VEGF in Cancer 1
- Co-authors
- C Korninger (2 shared papers)Johann Wojta (2 shared papers)Oswald Wagner (1 shared paper)Kurt Huber (2 shared papers)Johannes C. Kirchheimer (2 shared papers)Paul Viktor Ritschl (2 shared papers)Heinz Pflüger (2 shared papers)Michael Mildner (1 shared paper)
- Journals
- PubMed (16 papers)
In The Last Decade
Binder Br
15 papers receiving 382 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 189
- Hematology 101
- Immunology and Allergy 41
- Hepatology 50
- Internal Medicine 13
Countries citing papers authored by Binder Br
This map shows the geographic impact of Binder Br's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binder Br with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binder Br more than expected).
Fields of papers citing papers by Binder Br
This network shows the impact of papers produced by Binder Br. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binder Br. The network helps show where Binder Br may publish in the future.
Co-authors
The 25 scholars most cited alongside Binder Br, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. | 1999 | 125 |
| 2 | Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumors. | 1985 | 60 |
| 3 | Tissue plasminogen activator inhibitor in human plasma: development of a functional assay system and demonstration of a correlating Mr = 50,000 antiactivator. | 1985 | 47 |
| 4 | Characterization of a specific anti-human urokinase antibody: development of a sensitive competition radioimmunoassay for urokinase antigen. | 1984 | 38 |
| 5 | Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies. | 1987 | 36 |
| 6 | Increased plasma levels of urokinase-type plasminogen activator with endometrial and cervical cancer. | 1988 | 19 |
| 7 | Development and clinical use of an oral heat-inactivated whole cell pertussis vaccine. | 1985 | 18 |
| 8 | Influence of urokinase on cell proliferation and invasion. | 1990 | 15 |
| 9 | Plasminogen activator inhibitor-1 accelerates lung metastasis formation of human fibrosarcoma cells. | 1997 | 11 |
| 10 | Plasminogen activation in diabetes mellitus. Kinetics of plasmin formation with tissue plasminogen activator and plasminogen from individual diabetic donors and with in vitro glucosylated plasminogen. | 1988 | 9 |
| 11 | The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator. | 1993 | 8 |
| 12 | Myotonic dystrophy: molecular genetics and diagnosis. | 1998 | 5 |
| 13 | Dependence of urokallikrein excretion on the perfusion pressure in explanted perfused kidneys. | 1979 | 4 |
| 14 | [Tissue plasminogen activator activity in early prostatic cancer and in bone metastases of prostatic cancer]. | 1984 | 1 |
| 15 | Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease. | 1994 | 1 |
| 16 | [Pathophysiology of immobilization]. | 1999 | 1 |
About Binder Br
Binder Br is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Hematology and Oncology, having authored 16 papers that have together received 398 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (8 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Bone health and treatments (2 papers), Blood properties and coagulation (1 paper), Glycosylation and Glycoproteins Research (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Prostate Cancer Treatment and Research (1 paper) and Renal and Vascular Pathologies (1 paper). The work is most often cited by research in Cancer Research (189 citations), Hematology (101 citations), Immunology and Allergy (41 citations), Hepatology (50 citations) and Internal Medicine (13 citations). Binder Br has collaborated with scholars based in Austria, Japan and Czechia. Frequent co-authors include C Korninger, Johann Wojta, Oswald Wagner, Kurt Huber, Johannes C. Kirchheimer, Paul Viktor Ritschl, Heinz Pflüger, Michael Mildner, Johannes M. Breuss and Christoph Kaun. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.